As of Oct 15
| +0.24 / +2.18%|
The 2 analysts offering 12-month price forecasts for Fulgent Genetics Inc have a median target of 9.00, with a high estimate of 9.50 and a low estimate of 8.50. The median estimate represents a -20.14% decrease from the last price of 11.27.
The current consensus among 2 polled investment analysts is to Hold stock in Fulgent Genetics Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.